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cle under Abstract Background: The prevalence of neurological disorders in those aged
70 years and over in the Hai district of Tanzania has been previously reported.
The following research reports rates of patients: treatment seeking, diagnosis
and treatment within this prevalent population.
Methods: All people identified as having at least one neurological disorder in the
prevalence study were questioned regarding whether they had sought treatment for
their disorder, whether they had had a previous correct diagnosis and whether they
were being currently treated.
Results: From a background population of 2232 people, 349 people had neurolog-
ical disorders, of whom 225 (64.5%) had sought treatment for their symptoms. Of the
384 disorders identified in these 349 people, only 14.6% had been diagnosed and onlyCopyright ª 2012 Ministry of Health, Saudi Arabia. Published by Elsevier Ltd.
2.11.002
epartment of Medicine,
Lane, North Shields, Tyne
4 191 293 2709.
ctors.org.uk(F.Dewhurst).
the CC BY-NC-ND  license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
208 F. Dewhurst et al.9.9% were receiving appropriate treatment. Males were significantly more likely to
have been diagnosed and were more likely to have been treated appropriately.
Conclusions: Levels of diagnosis and treatment were low, with some gender
inequality. Reasons for this may include a lack of recognition of the condition within
the local population and lack of access to appropriate services. In the absence of
effective primary and secondary preventative measures, and effective treatment,
the burden of neurological disorders is likely to increase with further demographic
ageing.
Crown Copyright ª 2012 Ministry of Health, Saudi Arabia.Published by Elsevier
access article under theCC BY-NC-ND license(http://creativecommons.
B.V.
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org/licenses/by-nc-nd/4.0/).1. Introduction
1.1. Neurological disorders in high-income
countries
The annual economic cost of neurological diseases
in Europe in 2004 has been estimated at €139 bil-
lion (US$ 180 billion) [1]. This estimate did not in-
clude direct non-medical costs (e.g. community
care and informal care) and indirect costs. The
World Health Organization (WHO) has launched a
programme to scale up the treatment of people
with neurological disorders [2]. The WHO states
that even in high-income countries substantial
treatment gaps exist, with up to half the patients
affected by these conditions left untreated, and
most neurological problems are dealt with by gen-
eral practitioners and hospital physicians, rather
than by neurologists.
Neurological disorders account for 10–20% of
acute hospital admissions. Around 10% of the adult
population consult their general practitioner each
year with neurological symptoms, but less than
10% of these people are referred to hospital clinics.
Developments in the management of neurological
disorders are therefore relevant to doctors without
specialist neurological training [3].
In the past 10 years, new treatments have be-
come available for neurological disorders previously
considered untreatable (e.g. multiple sclerosis, Alz-
heimers disease, motor neuron disease). However,
the high cost of these treatments has sometimes led
to issues with health budgeting [3].
1.2. Neurological disorders in low- and
middle-income countries
Unfortunately, no equivalent estimates on the
financial cost of neurological disorders are avail-
able for low-income countries [4]. Nevertheless,
there can be little doubt that such disorders repre-
sent a significant burden at an individual and soci-
etal level [5,6]. Furthermore, access to effective
treatment is often hampered by lack of knowledgeof medical conditions and by beliefs that such
conditions are caused by evil spirits or witchcraft
[6–8].
1.3. Aims and objectives
The age-adjusted prevalence of people aged 70
years and over with neurological diagnoses in the
rural Hai district of Tanzania was previously re-
ported to be 154.1 per 1000 (95% CI: 139.2–169.1)
[9]. The primary aim of this study is to identify the
proportion of people seeking treatment, diagnosed
and on appropriate treatment for these conditions.
2. Methods
Ethical approval for the study was obtained locally
from Tumaini University ethics committee and
nationally from the Tanzanian National Institute
of Medical Research.
2.1. Design
The methods for the prevalence study have been
reported previously [9]. The data presented here
relate to rates of treatment seeking, diagnosis
and treatment of all those people identified as hav-
ing a neurological disorder in the prevalence study.
2.2. Setting and study population
The study setting has been described previously
and is only described briefly here [10]. The Hai dis-
trict of northern Tanzania is located around Mount
Kilimanjaro and includes a demographic surveil-
lance site (DSS) in which there are regular popula-
tion censuses. The most recent census was
completed on 1st June, 2009. It reported the pop-
ulation of the 52 villages in the district to be
161,119, of whom 8869 were aged 70 years and
over. Most villages have a small health centre or
a dispensary for basic treatment. There are three
small hospitals in the district, and a tertiary hospi-
tal in the adjacent district, Kilimanjaro Christian
Medical Centre.
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of the DSS population. Therefore, 12 villages were
selected (using a random number generator, with
stratification to allow a representative spread of
upland and lowland villages), with a total census
population of 2425. Exclusions, refusals and addi-
tions have been reported previously [9]. The final
cohort of participants was 2232 people.
2.3. Detection of neurological disorders and
data collection
Data were collected between 1st November, 2009
and 31st July, 2010. The point prevalence date
was the 1st January, 2010. Details of a screening
instrument which we have developed and validated
for neurological disorders in the elderly, was pub-
lished in the Journal of Neurology. This instrument
was used during the initial screening phase of the
current study [10]. The sensitivity of the instrument
was 87.8% and the specificity 94.9%. Participants
were seen at a place of their convenience (village
health centres or patients houses). Signed in-
formed consent was obtained from each partici-
pant. A thumbprint was obtained for those who
could not read and write and the purpose and impli-
cations of the study were verbally explained. In
cases where patients were unable to consent, writ-
ten assent was obtained from a close relative. The
neurology screening questionnaire was performed
by a trained non-medical investigator (NMI). Age,
sex, tribe, and level of disability (Barthel index
score [11]) were also recorded. Severe disability
was defined as a Barthel index score of <15 and
moderate disability as a Barthel index score of
15–18. All positive responders were seen by the re-
search doctor (FD) who performed a full neurologi-
cal history and examination to confirm or refute the
presence of a neurological disorder. Diagnoses of
positive responders were assigned using the World
Health Organizations (WHO) International Statisti-
cal Classification of Diseases and Related Health
Problems 10th Revision (ICD-10) [12]. Further spe-
cialist diagnoses were assigned as appropriate using
internationally recognised standard diagnostic cri-
teria. Details of all the diagnostic criteria used are
given in the Appendix. Physiological tremor was
not included. Headache had to be recurrent and af-
fect the ability of the participant to perform their
activities of daily living. All diagnoses were verified
with a neurologist (WH) or a movement disorder
expert (RW). Further details of the criteria used
have been published previously [9].
All participants identified as having a neurologi-
cal disorder were asked if they had sought treat-
ment for their condition and whether they werecurrently being treated for it. Treatment seeking
included visiting traditional healers and un-regis-
tered private pharmacies and dispensaries as well
as more formal healthcare facilities. If patients re-
sponded that they were receiving treatment, the
type and level of treatment was checked and
recorded.
2.4. Statistical analysis
Confidence intervals (CIs) for prevalence and for
odds ratios (OR) were calculated based on the
assumptions of the binomial distribution. No at-
tempt has been made to adjust our data for the ef-
fects of clustering of cases within villages.
3. Results
Of the study population of 2232 people, 1256
(56.3%) were female and 976 (43.7%) were male.
There were 384 cases of neurological disorders
amongst 349 people (35 people had two diagnoses).
The age-adjusted prevalence of at least one neuro-
logical disorder was 154.1 per 1000 (95% CI: 139.2–
169.1).
Of the 349 people with at least one neurological
disorder, 64.5% had sought treatment for their
symptoms. Of the 384 disorders, only 56 (14.6%)
had been diagnosed correctly and only 38 (9.9%)
had received appropriate treatment. A breakdown
of these figures by sex is presented in Table 1 and
by specific neurological disorders in Table 2. Males
with a neurological condition were significantly
more likely to be diagnosed than females (OR
2.05, 95% CI: 1.15–3.68). In cases where treatment
was available in Tanzania, males were more likely
to be treated, though the difference was not signif-
icant (OR 1.68, 95% CI: 0.85–3.32). The lack of sig-
nificance in the latter result is likely to be due in
part to the relatively small number of people being
treated, representing a Type II error.
Overall, there was no significant difference in
levels of disability between those who sought
treatment and those who did not. Of 159 who did
not seek treatment, 44 (27.7%) had moderate or se-
vere disability, whilst of 225 who sought treat-
ment, 67 (29.8%) had moderate or severe
disability, OR 1.10 (95% CI: 0.71–1.74). Rates of
treatment seeking and disability for selected neu-
rological disorders are detailed in Table 3. For each
specific disorder, the level of disability was not sig-
nificantly associated with whether a person sought
treatment or not. However, those disorders which
were associated with the highest level of disability
(epilepsy, stroke and Parkinsons disease) also had
the highest levels of treatment seeking.
Table 1 Treatment seeking behaviour and rates of diagnosis and treatment of people with neurological disorders.
Cases Number who
previously
sought
treatment
(%)
Number with
previous
diagnosis (%)
Number with
previous
appropriate
treatment (%)
Number for
whom
treatment
exists (%)
Number for whom
treatment exists in
Tanzania (%)
Males 182 in 162 Males 109 (59.9%) 35 (19.2%) 21 (11.5%) 152 (83.5%) 143 (78.6%)
Females 202 in 187 Females 116 (57.4%) 21 (10.4%) 17 (8.4%) 188 (93.1%) 183 (90.6%)
Total 384 (in 349 Individuals) 225 (58.6%) 56 (14.6%) 38 (9.9%) 340 (88.5%) 326 (84.9%)
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To the best of our knowledge, this is the first pub-
lished study of rates of diagnosis and treatment for
neurological disorders in SSA from within a preva-
lent population. They reveal that although almost
two-thirds of people with neurological disorders
had sought treatment for their condition, less than
one-tenth were on appropriate treatment.
4.1. Treatment seeking behaviour
Of the more common disorders, rates of treatment
seeking for stroke, epilepsy and Parkinsons disease
were high, whilst rates for tremor and headache
were low. Although the reasons why treatment is
sought for some conditions but not others are likely
to be complex, the extent to which a condition is
disabling appears not to be a significant factor.
Previous researchers who have investigated treat-
ment-seeking behavior in SSA have found that
whether people seek medical treatment for their
symptoms depends on a number of factors, such
as access to services, financial issues, education le-
vel, social networks, intra-household power and
health beliefs [5–8]. In the current study, rates
of treatment seeking were similar for males and fe-
males. There is a growing need for effective inter-
ventions for many medical conditions in SSA.
Further investigation of the factors which influence
treatment seeking will help to inform strategies for
the development of healthcare services in SSA.
4.2. Diagnosis and treatment
The majority of neurological disorders had not
been diagnosed prior to the study. This was despite
relatively high levels of treatment seeking. When
patients sought treatment, it was often not in
health centers and hospitals, but via un-registered
private pharmacies and traditional healers. In
these cases, an appropriate formal diagnosis was
rarely made. Of the most prevalent disorders,
stroke was the most likely to be diagnosed. Thosewho had been diagnosed were not necessarily trea-
ted, with just over two-thirds of those diagnosed
receiving appropriate treatment. Those least likely
to be receiving treatment when it was routinely
available were patients with tremor disorders,
and those most likely to be receiving treatment
(secondary prevention) were those patients with
a previous stroke. These generally low rates of
diagnosis and treatment may partly reflect pat-
terns of treatment-seeking behavior and health be-
liefs. However, in this resource-poor setting, it
may also be due to a lack of access to formal
healthcare.
The results of this study suggest some bias in
rates of diagnosis and treatment for neurological
disorders between men and women. There might
be a number of reasons for this. First, in a society
where healthcare is not free at the point of deliv-
ery, men are more likely to be the head of the
household and have the final decision on financial
matters [13,14]. When the male is the main pro-
vider of income, he must keep healthy and the
health of a husband and the children is often prior-
itised over that of the mother. Women have differ-
ent priorities in the home with the health of the
husband and children coming above their own
health [15]. Likewise, money for schooling and
food for other family members often comes before
the health of the mother [13]. Finally, women of-
ten hide symptoms if it reflects badly on their chil-
dren or grandchildren and their suitability for
marriage [16,17]. Such disparities are likely to be
deep rooted in society and are present from early
childhood in many cultures [18]. A study published
in 2012 of 4822 people aged 18 years and over in
Burkina Faso found a significantly higher preva-
lence of asthma, angina pectoris, back pain and
joint disease in women compared to men [19].
People with neurological disorders in this popu-
lation have been shown in this study to be signifi-
cantly more likely to be disabled than people
without neurological disorders [20]. Low diagnosis
and treatment rates are likely to exacerbate the
burden of non-communicable disease in SSA, a
Table 2 Treatment seeking behaviour and rates of diagnosis and treatment of people with neurological disorders split
into specific disorders.
Cases Number who
previously
sought
treatment (%)
Number with
previous
diagnosis (%)
Number with
previous
appropriate
treatment (%)
Number for
whom treatment
exists (%)
Number for
whom
treatment
exists in
Tanzania (%)
Central nervous system disorders
Movement disorders
Tremor – all causes
including cerebellar
disease and
Parkinsonism
110* 36 (32.7%) 6 (5.5%) 4 (3.6%) 103 (93.6%) 96 (87.3%)
Parkinsonism 14 10 (71.4%) 4 (28.6%) 3 (21.4%) 14 (100%) 14 (100%)
Cerebellar disorders 11 5 (45.5%) 2 (18.2%) 1 (9.1%) 4 (36.4%) 4 (36.4%)
Other dyskinesias 5 0 0 0 5 (100%) 2 (20%)
Episodic and paroxysmal disorders
Headache disorders 92 62 (67.4%) 4 (4.3%) 12 (13.0%) 92 (100%) 92 (100%)
Stroke 54 44 (81.5%) 36 (68.7%) 16 (29.6%) 54 (100%) 54 (100%)
Epilepsy 10 9 (90.0%) 2 (20.0%) 2 (20.0%) 10 (100%) 10 (100%)
Systemic atrophies/degenerative diseases affecting the central nervous system
Motor neuron disease 2 2 (100%) 0 0 2 (100%) 0
Injury resulting in CNS dysfunction
Spinal cord injury 5 4 (80.0%) 0 0 5 (100%) 0
Spinal cord dysfunction
– other
0 – – – – –
Infection resulting in
CNS dysfunction
0 – – – – –
Peripheral nervous system disorders
Polyneuropathies 42 21 (50.0%) 3 (7.1%) 4 (9.5%) 42 (100%) 42 (100%)
Nerve, nerve root and plexus disorders
Cranial nerves 14 14 (100%) 1 (7.1%) 0 4 (28.6%) 3 (21.4%)
Upper limb
mononeuropathies
15 6 (40.0%) 2 (13.3%) 0 8 (53.3%) 8 (53.3%)
Lower limb
mononeuropathies
5 4 (80.0%) 0 0 0 0
Plexus pathology 4 4 (100%) 1 (25.0%) 0 0 0
Root pathology 4 3 (75.0%) 0 0 3 (75.0%) 0
Inflammatory/infectious diseases of the peripheral nervous system
Polio 5 5 (100%) 2 (40.0%) 0 0 0
Leprosy 1 1 (100%) 1 (100%) 0 1 (100%) 1 (100%)
Diseases of the myoneural junction and muscle
Myasthenia gravis 1 0 0 0 1 (100%) 0
Muscle wasting and
atrophy
17 11 (64.7%) 0 0 15 (88.2%) 13 (76.5%)
* Including cases of tremor due to parkinsonism/Parkinsons disease (n = 12) and tremor due to cerebellar disorders (n = 11) but not
tremor due to stroke affecting the cerebellum (n = 4).
 Including cases of cerebellar disorders secondary to stroke (n = 4).
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Table 3 Treatment seeking behaviour and level of disability for selected neurological disorders.
Disorder Total number
who sought
treatment
Number with moderate or severe
disability (Barthel index <15)
Odds ratio (95% CI)
Treatment sought No treatment sought
Epilepsy (n = 10) 9 (90.0%) 8 (88.9%) 1 (100%) 0.52 (0.01–20.19)
Stroke (n = 54) 44 (81.5%) 28 (63.6%) 6 (60.0%) 1.17 (0.29–4.76)
Parkinsons disease (n = 14) 10 (71.4%) 6 (60.0%) 3 (75.0%) 0.50 (0.04–6.68)
Muscle wasting and atrophy (n = 17) 11 (64.7%) 7 (63.6%) 4 (66.6%) 0.95 (0.20–4.64)
Headache (n = 62) 32 (51.6%) 5 (15.6%) 9 (30.0%) 0.21 (0.06–0.68)
Peripheral polyneuropathy (n = 42) 21 (50.0%) 3 (14.3%) 5 (23.8%) 0.53 (0.11–2.59)
Tremor (n = 110) 36 (32.7%) 12 (33.3%) 15 (20.2%) 1.97 (0.80–4.81)
212 F. Dewhurst et al.burden which is predicted to increase substantially
as the population ages and the infection rates for
communicable diseases, such as HIV/AIDS, tuber-
culosis and malaria, decline [21–23].
4.3. Limitations
The limitations of the initial neurological disorders
prevalence study have been acknowledged [9]. The
main additional limitation that relates to the cur-
rent study is that a number of previous epidemio-
logical studies have been carried out in the Hai
district by this team of researchers over the last
10 years [6,24,25]. Consequently, rates of diagno-
sis and treatment may be higher than would be
found otherwise. Specifically, those who had had
a stroke were most likely to be receiving treatment
to prevent recurrence. This may be partly a reflec-
tion of the educational work done by the Tanzanian
Stroke Incidence Project, which ran from 2003 to
2006 [24]. Rates of secondary preventative treat-
ment for stroke in other areas of SSA have been re-
ported to be substantially lower [26].
5. Conclusions
This study has demonstrated low levels of diagnosis
and treatment of neurological disorders in the
community. Many neurological disorders can be
treated readily and inexpensively. However, the
reasons for these low rates are likely to be multi-
factorial and relate not only to availability and
affordability in the broadest sense, but also to
accessibility and cultural acceptability [8]. Identifi-
cation and diagnosis of those with neurological dis-
orders is clearly an important component in
reducing the morbidity burden in SSA. It has re-
cently been reported that African nations have
very limited numbers of neurologists and geriatri-
cians, with some countries having none [27,28].
As this situation is unlikely to change in the imme-diate future, other strategies to manage this bur-
den should be sought. Since diagnosis must
precede treatment, screening for neurological dis-
orders by NMI is an important first step to improv-
ing treatment rates. Programs to raise awareness
of medical conditions at a community level should
be considered. In addition, the training of primary
caregivers in the use of non-pharmacological inter-
ventions to manage such conditions should be con-
sidered. In the absence of initiatives to improve
rates of diagnosis and treatment, neurological mor-
bidity will continue to make a substantial, and
increasing, contribution to the non-communicable
disease epidemic in SSA [19].Funding
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Criteria. used for the diagnosis of specific
neurological conditions
• Essential tremor – Movement Disorder Society (MDS)
[1], National Institutes of Health (NIH) [2], Tremor
Research Investigation Group (TRIG) [3,4].
• Other tremors – Movement Disorder Society (MDS)
[1].
• Parkinsons disease – UK PDS Brain Bank Criteria/Mod-
ified Hoehn and Yahr [5,6].
• Vascular Parkinsonism – Winikates criteria [7].
• Progressive supranuclear palsy – National Institute of
Neurological Disorders and the Society for Progressive
Supranuclear Palsy (NINDS–SPSP) [8].
• Stroke – The Oxford Community Stroke Project Classi-
fication (OCSP)/Bamford Classification [9].
• Tardive dyskinesias – American Psychiatric Associa-
tion Task Force [10].
• Headaches – International Headache Society (IHS)
[11–16].
• Epilepsy – International League Against Epilepsy
(ILAE) [17,18].
• Motor Neuron Disease – National Institute of Neuro-
logical Disorders and Stroke (NINDS) [19].
• Spinal injury – American Spinal Injury Association
(ASIA) [20,21].
• Myasthenia gravis – Myasthenia Gravis Foundation of
America (MGFA) [22].
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